CapsoVision, Inc. (CV) Key Metrics
CV valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $347.5M
- Enterprise value
- $313.5M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 25.0
- Price / book
- 24.5
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- —
CV key metrics, 2023–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCV returns How much profit the business earns on the capital it uses.
CV per-share figures Results divided by the shares outstanding at year-end.
CV financial health Debt, liquidity and how easily interest is covered.
CV efficiency & capital use Working capital cycle and where the cash goes.
CV valuation history
CV returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CV debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CV price vs earnings per share
CV key metrics
2023–2025| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Valuation | |||
| Market capitalization | $501.0M | — | — |
| Enterprise value | $491.8M | — | — |
| Price / sales | 37.0 | — | — |
| Price / book | 37.8 | — | — |
| EV / sales | 36.3 | — | — |
| Earnings yield | −5.1% | — | — |
| Free cash flow yield | −4.6% | — | — |
| Share price at fiscal year-end | $10.69 | — | — |
| Per share | |||
| Revenue per share | $0.29 | $0.25 | $0.25 |
| Earnings per share | −$0.54 | −$0.43 | −$0.29 |
| Operating cash flow per share | −$0.49 | −$0.43 | −$0.28 |
| Free cash flow per share | −$0.49 | −$0.44 | −$0.30 |
| Cash per share | $0.22 | $0.20 | $0.38 |
| Book value per share | $0.28 | −$2.79 | −$2.84 |
| Tangible book value per share | $0.28 | −$2.79 | −$2.84 |
| Capex per share | $0.00 | $0.00 | $0.02 |
| Debt per share | $0.02 | $0.03 | $0.04 |
| Shares outstanding | 46.9M | 46.3M | 38.6M |
| Change in shares outstanding | +1.1% | +20.0% | — |
| Returns & profitability | |||
| Return on assets (ROA) | −144.8% | −103.8% | −52.5% |
| Return on tangible assets | −139.4% | −118.4% | −52.5% |
| Free cash flow margin | −169.4% | −172.2% | −118.5% |
| Financial health | |||
| Total debt | $887,000 | $1.2M | $1.5M |
| Cash & short-term investments | $10.1M | $9.3M | $14.6M |
| Net debt | −$9.2M | −$8.1M | −$13.0M |
| Debt / equity | 0.07 | — | — |
| Debt / assets | 0.05 | 0.07 | 0.07 |
| Current ratio | 3.77 | 8.24 | 12.74 |
| Quick ratio | 3.09 | 6.78 | 11.29 |
| Working capital | $12.2M | $13.0M | $17.7M |
| Invested capital | $4.0M | −$137.6M | −$122.9M |
| Tangible asset value | $13.3M | −$129.5M | −$109.8M |
| Net current asset value | $11.8M | −$131.5M | −$112.2M |
| Graham net-net per share | $0.18 | −$2.90 | −$2.96 |
| Capital allocation | |||
| Capex / revenue | 0.7% | 1.3% | 7.7% |
| Capex / depreciation | 0.16 | 0.29 | 1.94 |
| Stock-based compensation / revenue | 6.1% | 1.3% | 0.4% |
| R&D / revenue | 135.1% | 128.6% | 95.7% |
| SG&A / revenue | 106.1% | 95.0% | 77.0% |
| Efficiency | |||
| Days sales outstanding | 60.6 | 60.0 | 69.8 |
| Days of inventory on hand | 160.6 | 163.7 | 188.0 |
| Days payables outstanding | 54.1 | 37.7 | 30.9 |
| Cash conversion cycle (days) | 167.1 | 186.0 | 226.9 |
| Receivables turnover | 6.03 | 6.08 | 5.23 |
| Payables turnover | 6.75 | 9.69 | 11.81 |
| Inventory turnover | 2.27 | 2.23 | 1.94 |
| Asset turnover | 0.78 | 0.61 | 0.45 |
| Average receivables | $2.2M | $1.9M | $1.9M |
| Average payables | $946,000 | $555,000 | $361,000 |
| Average inventory | $2.8M | $2.4M | $2.2M |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% |
Computed from CV's annual financial statements (latest annual report filed March 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CV valuation and financial ratios
It ended the year with $0.9 million of debt and $10.1 million in cash and short-term investments, a net cash position of $9.2 million.
See the CV income statement, the CV chart for price history, or the CV stock overview for the latest quote and news.
CV key metrics FAQ
How much debt does CapsoVision have?
CapsoVision had total debt of $0.9 million at the end of fiscal 2025, a debt-to-equity ratio of 0.07 and more cash than debt.
What is CapsoVision's free cash flow yield?
CapsoVision generated -$23.0 million of free cash flow in fiscal 2025, a free cash flow yield of −4.6% on its market value at year-end ($501.0 million).
What is CapsoVision's current ratio?
CapsoVision's current ratio was 3.77 at the end of fiscal 2025: current assets were 3.77 times current liabilities.